BioLife Solutions Inc Total Liabilities
BioLife Solutions Inc total liabilities. Based on the latest financial reports, BioLife Solutions Inc (BLFS) has total liabilities worth $27.49 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of BioLife Solutions Inc to evaluate the company's liquid asset resilience ratio.
Total Liabilities of BioLife Solutions Inc (1988–2025)
Total liabilities of BioLife Solutions Inc from 1988 to 2025. This chart illustrates how BioLife Solutions Inc's total liabilities have evolved over time, based on quarterly financial data. Explore BioLife Solutions Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
BioLife Solutions Inc Competitors by Total Liabilities
The table below lists competitors of BioLife Solutions Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alony Hetz Properties and Investments Ltd
TA:ALHE
|
Israel | ILA34.24 Billion |
|
YY Inc Class A
NASDAQ:YY
|
USA | $2.76 Billion |
|
Costamare Inc
NYSE:CMRE
|
USA | $1.72 Billion |
|
Resolute Mining Ltd
AU:RSG
|
Australia | AU$498.14 Million |
|
Aarti Industries Limited
NSE:AARTIIND
|
India | Rs73.44 Billion |
|
Tecnoglass Inc
NYSE:TGLS
|
USA | $640.07 Million |
|
Nanjing Vazyme Biotech Co Ltd
SHG:688105
|
China | CN¥1.03 Billion |
|
Azad Engineering Limited
NSE:AZAD
|
India | Rs-15.29 Billion |
Liability Composition Analysis (1988–2025)
This chart breaks down BioLife Solutions Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BLFS total assets.
Liquidity & Leverage Metrics
BioLife Solutions Inc Total Liabilities Ratios Explained
BioLife Solutions Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioLife Solutions Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioLife Solutions Inc (1988–2025)
The table below shows the annual total liabilities of BioLife Solutions Inc from 1988 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $34.00 Million | -32.79% |
| 2024-12-31 | $50.58 Million | -32.61% |
| 2023-12-31 | $75.05 Million | -12.77% |
| 2022-12-31 | $86.04 Million | +12.86% |
| 2021-12-31 | $76.24 Million | +157.71% |
| 2020-12-31 | $29.58 Million | -40.07% |
| 2019-12-31 | $49.36 Million | +60.08% |
| 2018-12-31 | $30.84 Million | +1403.41% |
| 2017-12-31 | $2.05 Million | -56.92% |
| 2016-12-31 | $4.76 Million | +89.66% |
| 2015-12-31 | $2.51 Million | +17.49% |
| 2014-12-31 | $2.14 Million | -87.15% |
| 2013-12-31 | $16.62 Million | +6.19% |
| 2012-12-31 | $15.66 Million | +21.91% |
| 2011-12-31 | $12.84 Million | +18.28% |
| 2010-12-31 | $10.86 Million | +18.52% |
| 2009-12-31 | $9.16 Million | +44.45% |
| 2008-12-31 | $6.34 Million | +98.44% |
| 2007-12-31 | $3.20 Million | +740.25% |
| 2006-12-31 | $380.34K | -6.92% |
| 2005-12-31 | $408.62K | +85.48% |
| 2004-12-31 | $220.31K | -86.30% |
| 2003-12-31 | $1.61 Million | +85.21% |
| 2002-12-31 | $868.10K | -40.78% |
| 2001-12-31 | $1.47 Million | +306.87% |
| 2000-12-31 | $360.26K | -73.13% |
| 1999-12-31 | $1.34 Million | +3.46% |
| 1998-12-31 | $1.30 Million | -8.65% |
| 1997-12-31 | $1.42 Million | -30.81% |
| 1996-12-31 | $2.05 Million | -53.62% |
| 1995-12-31 | $4.42 Million | 0.00% |
| 1994-12-31 | $4.42 Million | +16.34% |
| 1993-12-31 | $3.80 Million | +35.71% |
| 1992-12-31 | $2.80 Million | +133.33% |
| 1991-12-31 | $1.20 Million | +1100.00% |
| 1990-12-31 | $100.00K | -50.00% |
| 1989-12-31 | $200.00K | -50.00% |
| 1988-12-31 | $400.00K | -- |
About BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more